MeMed - About the company
MeMed is a series D company based in Tirat Carmel (Israel), founded in 2009 by and . It operates as a Provider of machine learning based diagnostic solutions for infectious diseases. MeMed has raised $163M in funding from investors like , Ping An and Poalim Capital Markets. The company has 296 active competitors, including 78 funded and 44 that have exited. Its top competitors include companies like Visby Medical, Inflammatix and GenMark Diagnostics.
Company Details
MeMed Diagnostics provides machine learning-based diagnostic solutions for infectious diseases. The company's lead product ImmunoXpert, distinguishes between bacterial and viral infections based on the patient鈥檚 immune response in-vitro diagnostic test. The company also offers ImmunoPoC, a device for distinguishing between bacterial and viral infections at the point-of-care. The company also provides its immunoassay platform MeMed Key. Its solution also diagnoses infections inaccessible for direct pathogen sampling and avoids false alarms due to the presence of non-pathogenic bacteria and viruses.
- Website
- Social
Legal entities associated with MeMed
MeMed is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CIN: 15026415 United Kingdom, Deadpooled | Jul 24, 2023 | - | - |
Get your free copy of MeMed's company profile
MeMed's funding and investors
MeMed has raised a total funding of $163M over 10 rounds. Its first funding round was on Jul 23, 2015. Its latest funding round was a Series D round on Jan 10, 2022 for $93M. 11 investors participated in its latest round, lead by Shavit Capital, Union Tech Ventures, La Maison Partners, and Poalim Capital Markets.
MeMed has 23 institutional investors including , Ping An and Poalim Capital Markets. Jaan Tallinn and 1 other are Angel Investors in MeMed.
Here is the list of recent funding rounds of MeMed:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jan 10, 2022 | $93M | Series D | 9164844 | 3392211 | |
Jan 01, 2020 | $2.8M | Grant (prize money) | 7064347 | 4866327 | |
Nov 13, 2019 | $2.76M | Grant (prize money) | 5891221 | 9630854 |
Access funding benchmarks and valuations. Sign up today!View details of MeMed's funding rounds and investors
MeMed's founders and board of directors
The founders of MeMed are and .
Here are the details of MeMed's key team members:
- : Co-Founder & CTO of MeMed.
- : Co-Founder & CEO of MeMed.
View details of
Access 秘密研究所 on any website
Our Google Chrome extension lets you view company details while browsing their websites
MeMed's Competitors and alternates
Top competitors of MeMed include Visby Medical, Inflammatix and GenMark Diagnostics. Here is the list of Top 10 competitors of MeMed, ranked by 秘密研究所 score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st |  Visby Medical 2010, San Jose (United States), Series E | Developer of diagnostic products to detect infectious diseases | $331M | 64/100 | |
2nd | Inflammatix 2016, San Francisco (United States), Series E | Provider of diagnostic solutions for systemic infections | $191M | , DARPA听&补尘辫;听 | 64/100 |
3rd | 2009, Tirat Carmel (Israel), Series D | Provider of machine learning based diagnostic solutions for infectious diseases | $163M | Poalim Capital Markets, Shavit Capital听&补尘辫;听 | 62/100 |
4th | GenMark Diagnostics 1993, San Diego (United States), Acquired | Provider of instruments and test panels for multiplexed molecular diagnostics | $8.55M | 60/100 | |
5th |  Sunbird Bio 2020, Singapore, Series B | Developer of diagnostic technologies for the detection of infectious, cancer, and neurological diseases | $14M | EDBI, Arch Venture Partners听&补尘辫;听 | 58/100 |
6th |  T2 Biosystems 2006, Lexington (United States), Public | Developer of miniaturized MRI platforms for clinical diagnostics | $454M | Aisling Capital, SLR Investment Corp听&补尘辫;听 | 57/100 |
7th |  Karius 2014, Redwood City (United States), Series C | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | $315M | 55/100 | |
8th | Seegene Technologies 2000, Seoul (South Korea), Acquired | Developer of molecular diagnostic kits to detect infectious and genetic diseases | - | IMM Investment, Songhyun Investment听&补尘辫;听 | 54/100 |
9th | Developer of diagnostic solutions for sepsis and acute infections | $92.5M | 51/100 | ||
10th | Provider of qPCR-based molecular diagnostics platform | $78M | Talu Ventures, Northpond Ventures听&补尘辫;听 | 50/100 |
_1583132589582.png?height=40&width=40){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on MeMed's competitors? Click to see the top ones
MeMed's Investments and acquisitions
MeMed has made no investments or acquisitions yet.
Reports related to MeMed
Here is the latest report on MeMed's sector:
View
News related to MeMed
Media has covered MeMed for a total of 4 events in the last 1 year, 2 of them have been about company updates.
鈥�
Business Wire鈥�Jan 09, 2025鈥�MeMed
鈥�
Business Wire鈥�Jan 09, 2025鈥�MeMed
鈥�
LabPulse.com鈥�Dec 13, 2024鈥�MeMed
鈥�
Business Wire鈥�Dec 10, 2024鈥�MeMed
鈥�
GlobeNewswire鈥�Nov 09, 2023鈥�MeMed
鈥�
Medical Product Outsourcing鈥�Sep 22, 2023鈥�MeMed
鈥�
GlobeNewswire鈥�Jul 19, 2023鈥�MeMed
鈥�
鈥�
GlobeNewswire鈥�Apr 18, 2023鈥�MeMed
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about MeMed
Explore our recently published companies
- Zearup Biomed - Toronto based, Unfunded company
- Greenville Auto Auction - Greenville based, 2010 founded, Public company
- YiConnect - Hyderabad based, 2022 founded, Unfunded company
- Integrative Energy Medicine - Milford based, 2007 founded, Public company
- Marbury Group - Pittsburgh based, 2012 founded, Public company
- Supermind - Sydney based, 2025 founded, Unfunded company
